Is There Endometriosis Effect on Economic Burden?
Endometriosis imposes substantial direct and indirect economic burdens on women due to its chronic and recurring nature, impacting quality of life, fertility, and productivity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The paper asks whether endometriosis affects economic burden and conducts a PRISMA-guided selection of online articles, screening 122 papers down to 9 that were judged most relevant to the economic aspects of endometriosis. Across included discussions, the authors identify recurring and long-term nature of endometriosis—up to 40–45% recurrence—as an important driver, and describe both direct costs (recurring health expenses) and indirect costs (productivity losses, work absences, and excessive leave). A key limitation stated is that many records were excluded because they were not fully relevant, not specific to economic burden, were duplicates, lacked full text, or were older than 10 years, which restricts the breadth of evidence captured. This paper is centrally about endometriosis — it focuses specifically on whether and how endometriosis contributes to economic burden.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,793 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (14)
- Circulating oncomiR-21 as a potential biomarker of mild and severe forms of endometriosis for early diagnosis and management via openalex
- Economic burden of deep infiltrating endometriosis of the bowel and the bladder in Germany: The statutory health insurance perspective via openalex
- Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Pharmaceutical treatments to prevent recurrence of endometriosis following surgery: a model-based economic evaluation via openalex
- Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States via openalex
- The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey via openalex
- The direct and indirect costs associated with endometriosis: a systematic literature review via openalex
- The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States via openalex
- The influence of endometriosis-related symptoms on work life and work ability: a study of Danish endometriosis patients in employment via openalex
- W4213339239 via openalex
- W4225795233 via openalex
- W3180356331 via openalex
- W3014981627 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00